Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10434-000-0087-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage Melanoma

  1999cited by this paper
• [Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial].

  1999cited by this paper
• The Progression of Melanoma Nodal Metastasis Is Dependent on Tumor Thickness of the Primary Lesion

  1999cited by this paper
• Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

  1998cited by this paper
• Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

  1998cited by this paper
• A long-term analysis of 620 patients with malignant melanoma at a major referral center.

  1998cited by this paper
• Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

  1998cited by this paper
• The National Cancer Data Base report on cutaneous and noncutaneous melanoma

  1998cited by this paper
• Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

  1997cited by this paper
• Predicting ten‐year survival of patients with primary cutaneous melanoma

  1997cited by this paper
• Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

  1996cited by this paper
• Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

  1996cited by this paper
• A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma

  1996cited by this paper
• Observer variation in histological classification of cutaneous malignant melanoma.

  1995cited by this paper
• A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma

  1995cited by this paper
• Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients

  1995cited by this paper
• Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification

  1995cited by this paper
• Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.

  1994cited by this paper
• Application of multistage markov modeling to malignant melanoma progression

  1994cited by this paper
• The role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis

  1993cited by this paper
• Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

  1993cited by this paper
• Elective lymph node dissection in stage I malignant melanoma: a meta‐analysis

  1992cited by this paper
• Influence of gender on survival in patients with stage I malignant melanoma.

  1992cited by this paper
• Cutaneous melanoma: prognosis and treatment results worldwide.

  1992cited by this paper
• Technical details of intraoperative lymphatic mapping for early stage melanoma.

  1992cited by this paper
• Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional Nodes

  1991cited by this paper
• Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease

  1988cited by this paper
• The role of elective lymph node dissection in melanoma: rationale, results, and controversies.

  1988cited by this paper
• Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.

  1986cited by this paper
• Prognostic factors for stage I melanoma of the skin: a review.

  1985cited by this paper
• Prognostic groups of patients with stage I melanoma.

  1983cited by this paper
• Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.

  1983cited by this paper
• The Impact of Surgical Quality Control in Multi‐Institutional Group Trials Involving Adjuvant Cancer Treatments

  1983cited by this paper
• A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia

  1982cited by this paper
• Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis

  1982cited by this paper
• Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

  1982cited by this paper
• Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

  1982cited by this paper
• The prognostic significance of ulceration of cutaneous melanoma

  1980cited by this paper
• A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

  1979cited by this paper
• A new design for randomized clinical trials.

  1979cited by this paper
• Tumor thickness as a guide to surgical management of clinical stage I melanoma patients

  1979cited by this paper
• A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results

  1978cited by this paper
• A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging Methods

  1978cited by this paper
• Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.

  1977cited by this paper
• Selection of the Optimum Surgical Treatment of Stage I Melanoma By Depth of Microinvasion: Use of the Combined Microstage Technique (Clark‐Breslow)

  1975cited by this paper
• Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma

  1975cited by this paper

• Special Circumstances in the Management of Melanoma: Recurrence, Metastasis, and Non-surgical approaches.

  2026cites this paper
• Management of Early-Stage Melanoma and Merkel Cell Carcinoma.

  2025cites this paper
• Stellenwert der Chirurgie des malignen Melanoms im Kontext aktueller adjuvanter und neoadjuvanter Therapiekonzepte

  2025cites this paper
• Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations.

  2025cites this paper
• Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery?

  2025cites this paper
• Melanoma sentinel lymph node biopsy in the modern era.

  2024cites this paper
• The Impact of Surgical Margin in Wide Local Excision of Pediatric Melanoma - An Argument for a More Conservative Approach.

  2024cites this paper
• Biopsia ganglionului-santinelă: metodă de ultimă generaţie în stadializarea cancerului de col uterin

  2024cites this paper
• The particularities of the surgical treatment of patients with facial melanomas

  2024cites this paper
• Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions

  2024cites this paper
• Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy.

  2024cites this paper
• Entropy-Aware Similarity for Balanced Clustering: A Case Study With Melanoma Detection

  2023cites this paper
• Clinicopathological Features of Patients with Malignant Melanoma Diagnosis and Prognostic and Predictive Importance of Neuthrophil-Lymphocyte Ratio

  2023cites this paper
• The Evolution of the Sentinel Node Biopsy in Melanoma

  2023cites this paper
• Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment.

  2023cites this paper
• CP-GEP (Merlin) gene expression profiling: can my melanoma patient forgo sentinel lymph node biopsy?

  2023cites this paper
• Gene Identification and Potential Drug Therapy for Drug-Resistant Melanoma with Bioinformatics and Deep Learning Technology

  2022cites this paper
• Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States

  2022cites this paper
• Evaluating the effect of detection modalities in the Danish clinical follow-up program of cutaneous melanoma—a retrospective cohort study

  2022cites this paper
• Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3–5.8

  2022cites this paper
• Clinical Trials in Melanoma: Margins, Lymph Nodes, Targeted and Immunotherapy.

  2022cites this paper
• Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5.

  2022cites this paper
• The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021

  2022cites this paper
• Fifty years of progress in surgical oncology: Melanoma

  2022cites this paper
• Alternative Splicing of MDM4 in Human Melanomas

  2021cites this paper
• Current treatment strategy for resectable scalp and neck melanoma

  2021cites this paper
• Evaluation of Sentinel Lymph Node Status and its Association with Clinicopathological Factors in Patients with Cutaneous Melanoma: A Retrospective Study

  2021cites this paper
• Sentinel lymph node biopsy in head and neck cutaneous melanomas

  2021cites this paper
• Unusual Presentation of Giant Upper Limb Malignant Melanoma

  2021cites this paper
• Sentinel Lymph Node Biopsy and Nodal Surgery

  2021cites this paper
• American Joint Committee on Cancer Staging and Other Platforms to Assess Prognosis and Risk.

  2021cites this paper
• Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines

  2021cites this paper
• A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors

  2021cites this paper
• Factors influencing locoregional recurrence and distant metastasis in Asian patients with cutaneous melanoma after surgery: A retrospective analysis in a tertiary hospital in Taiwan

  2021cites this paper
• Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.

  2020cites this paper
• Management of Malignant Vulval Melanoma: A Retrospective Case Series and Review of the Literature

  2020cites this paper
• The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.

  2020cites this paper
• Can we reduce excision margins for head and neck melanoma? A 12-year retrospective study.

  2020cites this paper
• Nonsurgical Management of Lymph Node Basins in Melanoma.

  2020cites this paper
• Surgical Management of Lymph Nodes in Melanoma.

  2020cites this paper
• Melanoma

  2020cites this paper
• The Role of the Sentinel Lymph Node Biopsy in the Treatment of Nonmelanoma Skin Cancer and Cutaneous Melanoma

  2020cites this paper
• Sentinel Lymph Node Biopsy: Indications and Technique.

  2020cites this paper
• Biopsy of the Sentinel Lymph Node

  2020cites this paper
• The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes)

  2019cites this paper
• The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma

  2019cites this paper
• Melanoma Prognosis and Staging

  2019cites this paper
• Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology.

  2019cites this paper
• Primary Melanoma: from History to Actual Debates

  2019cites this paper
• Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea

  2019cites this paper
• From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50years.

  2019cites this paper
• Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma

  2019cites this paper
• Clinical Management of Primary Cutaneous Melanoma

  2019cites this paper
• Guidelines of care for the management of primary cutaneous melanoma.

  2019cites this paper
• An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection?

  2019cites this paper
• The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma

  2019cites this paper
• Surgical Considerations in Advance Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and Cutaneous Melanoma: a Head and Neck Perspective

  2018cites this paper
• Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers

  2018cites this paper
• Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials

  2018cites this paper
• National practice patterns of completion lymph node dissection for sentinel node‐positive melanoma

  2018cites this paper
• The Modern Approach to Targeting Melanoma

  2018cites this paper
• Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma

  2018cites this paper
• Surgical Management of Head and Neck Melanoma

  2018cites this paper
• Sentinel Lymph Node Biopsy for Melanoma

  2018cites this paper
• Completing the Dissection in Melanoma: Increasing Decision Precision

  2018cites this paper
• Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

  2018cites this paper
• Analysis of patients diagnosed with primary cutaneous melanoma in the last six years in Hospital Erasto Gaertner: epidemiologic profile

  2018cites this paper
• Current management of regional lymph nodes in patients with melanoma

  2018cites this paper
• History of Melanoma

  2018cites this paper
• A surgical perspective report on melanoma management.

  2017cites this paper
• Surgical Treatment of Primary Melanoma : Where Do We Stand After MSLT-II ?

  2017cites this paper
• Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.

  2017cites this paper
• Malignant Melanoma in the Adolescent and Young Adult (AYA) Population

  2017cites this paper
• Surgical Management of Melanoma

  2017cites this paper
• Completion lymph node dissection in patients with melanoma and positive sentinel lymph node biopsy.

  2017cites this paper
• Lymph node dissection for melanoma: where do we stand?

  2017cites this paper
• Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

  2017cites this paper
• Nonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes

  2017cites this paper
• Stratifying SLN incidence in intermediate thickness melanoma patients.

  2017cites this paper
• Melanoma Sentinel-Node Metastasis.

  2017cites this paper
• Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis

  2017cites this paper
• Sentinel node biopsy in melanoma: Current controversies addressed.

  2017cites this paper
• An Update on Randomized Clinical Trials in Melanoma.

  2017cites this paper
• Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

  2016cites this paper
• Chapter 42 – Malignant Melanoma

  2016cites this paper
• Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial

  2016cites this paper
• Management Controversies in Head and Neck Melanoma

  2016cites this paper
• Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck

  2016cites this paper
• The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.

  2016cites this paper
• Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle.

  2016cites this paper
• Surgical Management of Melanoma.

  2016cites this paper
• Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma.

  2016cites this paper
• Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.

  2016cites this paper
• Weighing the value of completion nodal dissection for melanoma

  2016cites this paper
• Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.

  2016cites this paper
• Population-Based Analysis of Completion Lymphadenectomy in Intermediate-Thickness Melanoma

  2016cites this paper
• Die prognostische Bedeutung der anatomischen Lokalisation, histologischer und klinischer Parameter für die Vorhersage von Lymphknotenmetastasen und das Gesamtüberleben bei Kopf-Hals-Melanomen

  2015cites this paper
• Radiation-induced pathologic complete response of gross nodal disease in recurrent head and neck melanoma

  2015cites this paper
• Current position of TNF-α in melanomagenesis

  2015cites this paper
• Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma

  2015cites this paper